Navigation Links
Gold Standard Re-launches ToxED Clinical Toxicology Poisoning and Drug Overdose Reference
Date:10/30/2008

New ToxED Meets Clinicians' Need for Detailed, Life-Saving Overdose Information at the Point-of-Care

ToxED offers free electronic 'Open House' in November

TAMPA, Fla., Oct. 30 /PRNewswire/ -- Setting a new standard for clinical toxicology poisoning and overdose references, Gold Standard Inc. has re-launched ToxED (http://www.ToxED.com). The newly updated and revised electronic clinical toxicology reference addresses clinicians' need for quick access to concise and comprehensive information at the point-of-care for the diagnosis and treatment of poisonings, drug overdoses, and exposure to chemicals and hazardous waste.

For the month of November, Gold Standard is offering a free electronic "Open House" to showcase the new version of ToxED. Just visit http://www.ToxED.com to register.

"ToxED is a crisp, concise, detailed, current and clinically relevant online resource designed to help clinicians get the information they need to support clinical care," said Michael W. Shannon, M.D., MPH, the Medical Editor-in-Chief of ToxED and co-chair of the ToxED Board. Dr. Shannon is also Chief Emeritus, Division of Emergency Medicine at Children's Hospital, Boston, and a Professor of Pediatrics at Harvard Medical School. "No other source in toxicology delivers information and insight of comparable timeliness and quality delivered in an easy-to-navigate and access format."

More than 2.4 million poisonings were reported to the American Association of Poison Control Centers in 2005, and approximately 23 percent of those cases required treatment in a healthcare facility. Nearly 1,300 were fatal. On average nationally, poison control centers handle one poison exposure every 14 seconds, and 53 percent of poison exposures occur in children under the age of six.

The first version of ToxED, introduced in 2006, offered clinicians limited insight
'/>"/>

SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
2. American Medical Association Endorses CAQH CORE Effort to Standardize and Streamline Patient Administrative Data Exchange
3. National Quality Forum Endorses National Consensus Standards for Perinatal Care
4. RevenueMed and Anodyne Health Partner to Raise the Standard of Payment Posting Services
5. New EPA Lead Standard Significantly Improved to Protect Kids Health
6. Call for new standards of care in arthritis/rheumatism
7. SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2
8. GHX to Become GDSN-certified Data Pool to Accelerate Use of GS1 Standards in Healthcare
9. California Senate Rejects Proposed Effort to Weaken Fire Safety Standards
10. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
11. Physician Recruiting Standard Reveals Larger Populations Experiencing Increased Doctor Shortage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...gate Endpoints of Long-Term Survival in Prostate C...ant metastases 3 years after the start of treatmen...l in patients with early prostate cancer. , Prost...cause patients must be followed for many years. If...
...ity improved 22 percent as a result of My Health p...ated Benefits Institute (IBI) and the National Bus...e Mutual Insurance Company with the 2009 IBI/NBCH ... Reuters, recognizes leadership in the area of hea...
...r to have an effect on whether a patient with term...to a study led by researchers at Beth Israel Deaco...ary 2009 issue of the Journal of the American Ger...s and Hispanics. , According to senior author Ell...
...n Medicine announced today the results from an ong...6 at the 16th Conference on Retroviruses and Oppor... a gene therapy product being investigated for the... from their current antiretroviral therapy. , "W...
...l Insurance Company is one of 10 employers across ...Deserved Award. The award recognizes employers who...yees, health. , , UnitedHealthcare provides healt...ard applicants. Criteria included executive suppor...
...s just-released 2009 AEC Industry Outlook: Strate... reveals a shake-up in the markets that firm lead...ental consulting industries expect to be most prom...e ranked markets (higher education, K-12 schools, ...
Other Medicine News:Health News:Also in the Feb. 10 JNCI 2Health News:Also in the Feb. 10 JNCI 3Health News:Also in the Feb. 10 JNCI 4Health News:Also in the Feb. 10 JNCI 5Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 2Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 3Health News:Study finds race and ethnicity affect use of hospice services among patients with advanced cancer 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Texas Mutual Wins National Employee Wellness Award 2Health News:New Study Reveals Shake-Up in the Most Promising AEC Markets for 2009 2
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Mammography Equipment - A Global Market Pers...330/Mammography-Equipment---A-Global-Market-Perspe...r in industrialized as well as developing nations ...mmography market. Globally, escalating awareness a...
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 1FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 2FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 3FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 4FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 5FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 7FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 8PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 1PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 3Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 1Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 2Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 3
...ain cell that was long overlooked by researchers e...ain differs fundamentally from that of a mouse or ...findings as the cover story in the March 11 issue ...at the University of Rochester Medical Center fo...ought simply to support flashier brain cells known...
.../ -- Results from the Phase II portion of a Phas...nal drug relaxin for the treatment of acute heart ...day, March 29, at the American College of Cardiolo...do, Fla. , , John R. Teerlink, M.D., professor of... , Director of Heart Failure, San Francisco Vetera...
Other Medicine Technology:Astrocytes Help Separate Man From Mouse 2Astrocytes Help Separate Man From Mouse 3Astrocytes Help Separate Man From Mouse 4Astrocytes Help Separate Man From Mouse 5Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Ascent Anterior Referencing Femoral Instrument Case
Ascent Knee System Case # 2
Lineage Acetabular Cup System (Ceramic)
Medicine Products: